Stay updated on Pembro & HER2Bi-ACT for Met CRPC Clinical Trial
Sign up to get notified when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.

Latest updates to the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, representing a backend/template update. This does not modify the displayed study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated to v3.6.5, replacing the previous v3.6.4, indicating a new site release. The update does not change the study details or other user-facing content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a newer version of the ClinicalTrials.gov record was published. This appears to be a small update to the page's metadata rather than a change to the study data.SummaryDifference0.1%

- Check69 days agoChange DetectedA Publications section has been added, including a PubMed citation for related literature (Phase II trial work) and a note that publications are automatically filled from PubMed. This adds related literature context to the study record.SummaryDifference0.3%

- Check76 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3. This is a minor revision update and does not modify the study details or other user-facing content.SummaryDifference0.1%

- Check90 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new sections were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment heading formatting changed and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Pembro & HER2Bi-ACT for Met CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.